-
1
-
-
70449370231
-
Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer
-
Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM 2009 Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167-1214.
-
(2009)
Thyroid
, vol.19
, pp. 1167-1214
-
-
Cooper, D.S.1
Doherty, G.M.2
Haugen, B.R.3
Kloos, R.T.4
Lee, S.L.5
Mandel, S.J.6
Mazzaferri, E.L.7
McIver, B.8
Pacini, F.9
Schlumberger, M.10
Sherman, S.I.11
Steward, D.L.12
Tuttle, R.M.13
-
2
-
-
84872600864
-
-
Thyroid Cancer Panel 2012 National Comprehensive Cancer Network, Clinical Practice Guidelines in Oncology (accessed 20 Dec
-
Thyroid Cancer Panel 2012 National Comprehensive Cancer Network, Clinical Practice Guidelines in Oncology, Thyroid Cancer. www.nccn.org/index.asp (accessed 20 Dec 2011).
-
(2011)
Thyroid Cancer
-
-
-
3
-
-
33745684505
-
European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium
-
Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W 2006 European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 154:787-803.
-
(2006)
Eur. J. Endocrinol.
, vol.154
, pp. 787-803
-
-
Pacini, F.1
Schlumberger, M.2
Dralle, H.3
Elisei, R.4
Smit, J.W.5
Wiersinga, W.6
-
4
-
-
25144481447
-
Long-term course and predictive factors of elevated serum thyroglobulin and negative diagnostic radioiodine whole body scan in differentiated thyroid cancer
-
Alzahrani AS, Mohamed G, Al Shammary A, Aldasouqi S, Abdal Salam S, Shoukri M 2005 Long-term course and predictive factors of elevated serum thyroglobulin and negative diagnostic radioiodine whole body scan in differentiated thyroid cancer. J Endocrinol Invest 28:540-546.
-
(2005)
J. Endocrinol. Invest.
, vol.28
, pp. 540-546
-
-
Alzahrani, A.S.1
Mohamed, G.2
Al Shammary, A.3
Aldasouqi, S.4
Abdal Salam, S.5
Shoukri, M.6
-
5
-
-
0037342073
-
Positive predictive value of serum thyroglobulin levels, measured during the first year of follow-up after thyroid hormone withdrawal, in thyroid cancer patients
-
Baudin E, Do Cao C, Cailleux AF, Leboulleux S, Travagli JP, Schlumberger M 2003 Positive predictive value of serum thyroglobulin levels, measured during the first year of follow-up after thyroid hormone withdrawal, in thyroid cancer patients. J Clin Endocrinol Metab 88:1107-1111.
-
(2003)
J. Clin. Endocrinol. Metab.
, vol.88
, pp. 1107-1111
-
-
Baudin, E.1
Do Cao, C.2
Cailleux, A.F.3
Leboulleux, S.4
Travagli, J.P.5
Schlumberger, M.6
-
6
-
-
79953689267
-
Favourable course of disease after incomplete remission on (131)I therapy in children with pulmonary metastases of papillary thyroid carcinoma: 10 years followup
-
Biko J, Reiners C, Kreissl MC, Verburg FA, Demidchik Y, Drozd V 2011 Favourable course of disease after incomplete remission on (131)I therapy in children with pulmonary metastases of papillary thyroid carcinoma: 10 years followup. Eur J Nucl Med Mol Imaging 38:651-655.
-
(2011)
Eur. J. Nucl. Med. Mol. Imaging
, vol.38
, pp. 651-655
-
-
Biko, J.1
Reiners, C.2
Kreissl, M.C.3
Verburg, F.A.4
Demidchik, Y.5
Drozd, V.6
-
7
-
-
0023181518
-
Serial serum thyroglobulin measurements in the management of differentiated thyroid carcinoma
-
Black EG, Sheppard MC, Hoffenberg R 1987 Serial serum thyroglobulin measurements in the management of differentiated thyroid carcinoma. Clin Endocrinol (Oxf ) 27:115-120.
-
(1987)
Clin. Endocrinol. (Oxf )
, vol.27
, pp. 115-120
-
-
Black, E.G.1
Sheppard, M.C.2
Hoffenberg, R.3
-
8
-
-
34347358669
-
Patients treated for differentiated thyroid cancer with negative 131I whole-body scans and elevated thyroglobulin levels: A possible course]
-
Gutierrez Cardo AL, Rodriguez Rodriguez JR, Borrego Dorado I, Navarro Gonzalez E, Tirado Hospital JL, Vazquez Albertino R 2007 [Patients treated for differentiated thyroid cancer with negative 131I whole-body scans and elevated thyroglobulin levels: A possible course]. Rev Esp Med Nucl 26:138-145.
-
(2007)
Rev. Esp. Med. Nucl.
, vol.26
, pp. 138-145
-
-
Gutierrez Cardo, A.L.1
Rodriguez Rodriguez, J.R.2
Borrego Dorado, I.3
Navarro Gonzalez, E.4
Tirado Hospital, J.L.5
Vazquez Albertino, R.6
-
9
-
-
33846149990
-
Sequential follow-up of serum thyroglobulin and whole body scan in thyroid cancer patients without initial metastasis
-
Huang SH, Wang PW, Huang YE, Chou FF, Liu RT, Tung SC, Chen JF, Kuo MC, Hsieh JR, Hsieh HH 2006 Sequential follow-up of serum thyroglobulin and whole body scan in thyroid cancer patients without initial metastasis. Thyroid 16:1273-1278.
-
(2006)
Thyroid
, vol.16
, pp. 1273-1278
-
-
Huang, S.H.1
Wang, P.W.2
Huang, Y.E.3
Chou, F.F.4
Liu, R.T.5
Tung, S.C.6
Chen, J.F.7
Kuo, M.C.8
Hsieh, J.R.9
Hsieh, H.H.10
-
10
-
-
77749267572
-
Empiric highdose 131-iodine therapy lacks efficacy for treated papillary thyroid cancer patients with detectable serum thyroglobulin, but negative cervical sonography and 18F-fluorodeoxyglucose positron emission tomography scan
-
Kim WG, Ryu JS, Kim EY, Lee JH, Baek JH, Yoon JH, Hong SJ, Kim ES, Kim TY, Kim WB, Shong YK 2011 Empiric highdose 131-iodine therapy lacks efficacy for treated papillary thyroid cancer patients with detectable serum thyroglobulin, but negative cervical sonography and 18F-fluorodeoxyglucose positron emission tomography scan. J Clin Endocrinol Metab 95:1169-1173.
-
(2011)
J. Clin. Endocrinol. Metab.
, vol.95
, pp. 1169-1173
-
-
Kim, W.G.1
Ryu, J.S.2
Kim, E.Y.3
Lee, J.H.4
Baek, J.H.5
Yoon, J.H.6
Hong, S.J.7
Kim, E.S.8
Kim, T.Y.9
Kim, W.B.10
Shong, Y.K.11
-
11
-
-
0028333953
-
Serum thyroglobulin in the follow-up of patients with treated differentiated thyroid cancer
-
Ozata M, Suzuki S, Miyamoto T, Liu RT, Fierro-Renoy F, DeGroot LJ 1994 Serum thyroglobulin in the follow-up of patients with treated differentiated thyroid cancer. J Clin Endocrinol Metab 79:98-105.
-
(1994)
J. Clin. Endocrinol. Metab.
, vol.79
, pp. 98-105
-
-
Ozata, M.1
Suzuki, S.2
Miyamoto, T.3
Liu, R.T.4
Fierro-Renoy, F.5
DeGroot, L.J.6
-
12
-
-
0034840812
-
Outcome of differentiated thyroid cancer with detectable serum Tg and negative diagnostic (131)I whole body scan: Comparison of patients treated with high (131)I activities versus untreated patients
-
Pacini F, Agate L, Elisei R, Capezzone M, Ceccarelli C, Lippi F, Molinaro E, Pinchera A 2001 Outcome of differentiated thyroid cancer with detectable serum Tg and negative diagnostic (131)I whole body scan: Comparison of patients treated with high (131)I activities versus untreated patients. J Clin Endocrinol Metab 86:4092-4097.
-
(2001)
J. Clin. Endocrinol. Metab.
, vol.86
, pp. 4092-4097
-
-
Pacini, F.1
Agate, L.2
Elisei, R.3
Capezzone, M.4
Ceccarelli, C.5
Lippi, F.6
Molinaro, E.7
Pinchera, A.8
-
13
-
-
0029006508
-
Iodine-131 therapy for thyroid cancer patients with elevated thyroglobulin and negative diagnostic scan
-
Pineda JD, Lee T, Ain K, Reynolds JC, Robbins J 1995 Iodine-131 therapy for thyroid cancer patients with elevated thyroglobulin and negative diagnostic scan. J Clin Endocrinol Metab 80:1488-1492.
-
(1995)
J. Clin. Endocrinol. Metab.
, vol.80
, pp. 1488-1492
-
-
Pineda, J.D.1
Lee, T.2
Ain, K.3
Reynolds, J.C.4
Robbins, J.5
-
14
-
-
64249099411
-
-
Seventh edition. Springer- Verlag New York
-
Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. (Eds.) 2009 AJCC Cancer Staging Manual, Seventh edition. Springer-Verlag, New York.
-
(2009)
AJCC Cancer Staging Manual
-
-
Edge, S.B.1
Byrd, D.R.2
Compton, C.C.3
Fritz, A.G.4
Greene, F.L.5
Trotti, A.6
-
15
-
-
78649701492
-
Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: Using response to therapy variables to modify the initial risk estimates predicted by the new american thyroid association staging system
-
Tuttle RM, Tala H, Shah J, Leboeuf R, Ghossein R, Gonen M, Brokhin M, Omry G, Fagin JA, Shaha A 2010 Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: Using response to therapy variables to modify the initial risk estimates predicted by the new american thyroid association staging system. Thyroid 20:1341-1349.
-
(2010)
Thyroid
, vol.20
, pp. 1341-1349
-
-
Tuttle, R.M.1
Tala, H.2
Shah, J.3
Leboeuf, R.4
Ghossein, R.5
Gonen, M.6
Brokhin, M.7
Omry, G.8
Fagin, J.A.9
Shaha, A.10
-
16
-
-
10344243496
-
Factors influencing the basal and recombinant human thyrotropin- stimulated serum thyroglobulin in patients with metastatic thyroid carcinoma
-
Robbins RJ, Srivastava S, Shaha A, Ghossein R, Larson SM, Fleisher M, Tuttle RM 2004 Factors influencing the basal and recombinant human thyrotropin-stimulated serum thyroglobulin in patients with metastatic thyroid carcinoma. J Clin Endocrinol Metab 89:6010-6016.
-
(2004)
J. Clin. Endocrinol. Metab.
, vol.89
, pp. 6010-6016
-
-
Robbins, R.J.1
Srivastava, S.2
Shaha, A.3
Ghossein, R.4
Larson, S.M.5
Fleisher, M.6
Tuttle, R.M.7
-
17
-
-
79959824376
-
Prognostic impact of serum thyroglobulin doublingtime under TSH suppression in patients with papillary thyroid carcinoma who underwent total thyroidectomy
-
Miyauchi A, Kudo T, Miya A, Kobayashi K, Ito Y, Shimoyamate-dori C, Takamura Y, Higashiyama T, Fukushima M, Kihara M, Tomoda C, Inoue H, Yabuta T, Masuoka H 2011 Prognostic impact of serum thyroglobulin doublingtime under TSH suppression in patients with papillary thyroid carcinoma who underwent total thyroidectomy. Thyroid 21:691-692.
-
(2011)
Thyroid
, vol.21
, pp. 691-692
-
-
Miyauchi, A.1
Kudo, T.2
Miya, A.3
Kobayashi, K.4
Ito, Y.5
Shimoyamate-dori, C.6
Takamura, Y.7
Higashiyama, T.8
Fukushima, M.9
Kihara, M.10
Tomoda, C.11
Inoue, H.12
Yabuta, T.13
Masuoka, H.14
-
18
-
-
82955161584
-
In differentiated thyroid cancer, an incomplete structural response to therapy is associated with significantly worse clinical outcomes than only an incomplete thyroglobulin response
-
Vaisman F, Tala H, Grewal R, Tuttle RM 2011 In differentiated thyroid cancer, an incomplete structural response to therapy is associated with significantly worse clinical outcomes than only an incomplete thyroglobulin response. Thyroid 21:1317-1322.
-
(2011)
Thyroid
, vol.21
, pp. 1317-1322
-
-
Vaisman, F.1
Tala, H.2
Grewal, R.3
Tuttle, R.M.4
-
19
-
-
79955653371
-
Current thyroglobulin autoantibody (TgAb) assays often fail to detect interfering TgAb that can result in the reporting of falsely low/undetectable serum Tg IMA values for patients with differentiated thyroid cancer
-
Spencer C, Petrovic I, Fatemi S 2011 Current thyroglobulin autoantibody (TgAb) assays often fail to detect interfering TgAb that can result in the reporting of falsely low/undetectable serum Tg IMA values for patients with differentiated thyroid cancer. J Clin Endocrinol Metab 96: 1283-1291.
-
(2011)
J. Clin. Endocrinol. Metab.
, vol.96
, pp. 1283-1291
-
-
Spencer, C.1
Petrovic, I.2
Fatemi, S.3
-
20
-
-
0141787986
-
Radioiodine treatment with 30 mCi after recombinant human thyrotropin stimulation in thyroid cancer: Effectiveness for postsurgical remnants ablation and possible role of iodine content in L-thyroxine in the outcome of ablation
-
Barbaro D, Boni G, Meucci G, Simi U, Lapi P, Orsini P, Pasquini C, Piazza F, Caciagli M, Mariani G 2003 Radioiodine treatment with 30 mCi after recombinant human thyrotropin stimulation in thyroid cancer: Effectiveness for postsurgical remnants ablation and possible role of iodine content in L-thyroxine in the outcome of ablation. J Clin Endocrinol Metab 88:4110-4115.
-
(2003)
J. Clin. Endocrinol. Metab.
, vol.88
, pp. 4110-4115
-
-
Barbaro, D.1
Boni, G.2
Meucci, G.3
Simi, U.4
Lapi, P.5
Orsini, P.6
Pasquini, C.7
Piazza, F.8
Caciagli, M.9
Mariani, G.10
|